StockData
Solventum Corp logo

Solventum Corp (SOLV) company profile

SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3095% above fair value
$89.08+0.27 (+0.30%)

Close on Nov 13, 2026Market cap $15.16BP/E 100.1Yield –

About Solventum

Surgical & Medical Instruments & Apparatus, SIC 3841

Solventum Corporation is a global healthcare enterprise that develops, manufactures, and commercializes clinical and technological solutions. The company operates across three core business segments: MedSurg, Dental Solutions, and Health Information Systems. Its MedSurg portfolio encompasses negative pressure wound therapy, dressings, surgical supplies, and infection-prevention devices. The Dental Solutions division delivers restorative materials, cements, and orthodontic equipment covering comprehensive tooth care. Through its Health Information Systems unit, the organization supplies documentation software, automated billing and coding platforms, speech recognition, and data tools. Solventum sells its products and services directly and through partner networks to multidisciplinary hospitals, private clinics, physicians, and dental practitioners.

The company maintains a worldwide commercial presence with sales spanning more than 90 countries. Solventum employs approximately 20,000 workers across its global facilities, including roughly 10,000 staff members in the United States and about 2,000 in Germany. Around 4,000 team members work as production staff in international manufacturing plants. Operating through a global hub-and-spoke distribution model, the company maintains regional supply networks and worldwide production centers. The provided text does not state the city or country of its corporate headquarters.

Summary of the business section of Solventum's latest annual report, written by StockData.

Company profile

Company

Legal name
Solventum Corp
Founded
2024
Headquarters
Eagan, MN
Address
1750 Yankee Doodle Road 55121
Phone
(651) 733-1110
Employees
10,000, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, Minneapolis, Minnesota

Stock & identifiers

Ticker
SOLV
Exchange
NYSE
IPO date
Mar 26, 2024
Shares outstanding
170M, Jul 31, 2026
Public float
$13.10B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1964738
CUSIP
83444M101
ISIN
US83444M1018
FIGI
BBG018YZH6T3
Share class FIGI
BBG018YZH6V0
LEI
254900I70403OSGY4M28
EIN
92-2008841

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Bryan C. HansonChief Executive Officer, Director185,515
Neil Craig ZieselmanSVP, Controller & CAO–
Marcela A. KirbergerChief Legal Affairs Officer15,492
Tammy L. GomezChief Human Resources Officer15,030
Amy LanducciChief Information Officer39,888
Wayde D. McMillanChief Financial Officer53,041
Paul S. HarringtonChief Supply Chain Officer20,452
Mary T. WilcoxChief Accounting Officer6,904
Heather KnightChief Commercial Officer–
Chris BarryExecutive Vice President4,624
Corp SolventumChief Legal Affairs Officer2,569
Susan D. DeVoreDirector8,947
Amy McBride WendellDirector10,422
Shirley Ann EdwardsDirector8,947
Karen J. MayDirector8,947
Carrie Smith CoxDirector16,400
Bernard A. Harris JrDirector8,947
John H. WeilandDirector8,947
Carlos AlbanDirector8,947
Glenn A. EisenbergDirector8,947
Darryl L. WilsonDirector8,947
Elizabeth MilyDirector9,009

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$20.14M$40.02M$5.07M$115$109
FY2024$39.96M$40.24M$8.53M$96$95

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsIncentive payOtherTotalvs. prior year
Bryan C. Hanson
Chief Executive Officer
$1.35M–$15.21M$2.99M$592.06K$20.14M-50%
Wayde D. McMillan
Chief Financial Officer
$773.23K–$4.20M$1.12M$78.45K$6.17M-40%
Heather Knight
Chief Commercial Officer
$112.82K$2.00M$5.65M$140.19K$11.37K$7.92M–
Marcela A. Kirberger
Chief Corporate & Legal Officer
$728.65K–$1.99M$773.09K$99.40K$3.59M–
Amy L. Landucci
Chief Information & Digital Officer
$684.88K–$1.81M$871.97K$98.72K$3.46M-62%
Christopher Barry
Former EVP and Group President, Medical Surgical
$996.75K–$3.15M–$88.55K$4.23M-57%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“We have approximately 10,000 employees in the United States and approximately 2,000 in Germany.”

Corporate history

Events identified from SEC filings

DateEventDetails
Sep 2, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Nov 15, 2024MergerRegistration of securities for a merger or exchange offer (S-4)
Feb 20, 2024Spin-offRegistration as a new public company (Form 10), e.g. spin-off
Feb 9, 2024Name changeName changed from 3M Health Care Co to Solventum Corp

See a number that looks wrong?